VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
YARW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
YARWYarrow Bioscience Inc
$15.60$145M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksYARWQuarterly Financials

Yarrow Bioscience Inc (YARW) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Yarrow Bioscience Inc (YARW) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

YARW Income Statement

Quarterly statement

YARW Income Statement

Yarrow Bioscience Inc (YARW) annual income statement — 11-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue97K86K130K169K69K202K84K121K198K98K76K114K135K99K6K167K126K178K2.29M133K
Revenue Growth %40.58%-57.43%54.76%39.67%-65.15%106.12%----1166.67%-31.74%7.14%-44.38%-99.74%25.56%-57.29%-22.61%-46.52%-95.93%
Cost of Goods Sold6K6K0000000000000000903K28K
COGS % of Revenue6.19%6.98%----------------39.4%21.05%
Gross Profit91K80K130K169K69K202K84K121K198K98K76K114K135K99K6K167K126K178K1.39M105K
Gross Margin %93.81%93.02%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%60.6%78.95%
Gross Profit Growth %31.88%-60.4%54.76%39.67%-65.15%106.12%----1166.67%-31.74%7.14%-44.38%-99.57%59.05%-52.81%-22.61%-62.98%-96.38%
Operating Expenses3.19M3.9M5.35M7.96M7.61M9.4M12.85M13.21M10.59M7.48M6.91M6.35M10.45M5.97M7.99M9.5M8.41M8.87M-10.65M10.87M
OpEx % of Revenue3291.75%4530.23%4114.62%4710.65%11030.43%4652.97%15302.38%10919.01%5350.51%7630.61%9089.47%5568.42%7742.96%6034.34%133166.67%5688.62%6676.98%4982.58%-464.88%8174.44%
Selling, General & Admin2.41M3.08M2.37M2.71M2.73M3.27M3.17M2.96M3.29M3.77M3.88M3.03M3.22M3.24M3.71M3.95M4.3M4.42M8.2M4.96M
SG&A % of Revenue2485.57%3580.23%1824.62%1600.59%3956.52%1621.29%3773.81%2449.59%1660.61%3846.94%5111.84%2657.89%2385.19%3272.73%61850%2367.66%3416.67%2481.46%357.68%3725.56%
Research & Development788K817K2.98M5.26M4.88M6.12M9.68M10.25M7.31M3.71M3.02M3.32M7.23M2.73M4.28M5.55M4.11M4.45M5.24M5.92M
R&D % of Revenue812.37%950%2290%3110.06%7073.91%3031.68%11528.57%8469.42%3689.9%3783.67%3977.63%2910.53%5357.78%2761.62%71316.67%3320.96%3260.32%2501.12%228.4%4448.87%
Other Operating Expenses-6K00000000000000010-1000K0
Operating Income-3.1M-3.82M-5.22M-7.79M-7.54M-9.2M-12.77M-13.09M-10.4M-7.38M-6.83M-6.23M-10.32M-5.88M-7.98M-9.33M-8.29M-8.69M12.04M-10.77M
Operating Margin %-3197.94%-4437.21%-4014.62%-4610.65%-10930.43%-4552.97%-15202.38%-10819.01%-5250.51%-7530.61%-8989.47%-5468.42%-7642.96%-5934.34%-133066.67%-5588.62%-6576.98%-4882.58%525.48%-8095.49%
Operating Income Growth %58.87%58.51%59.13%40.48%27.45%-24.62%----14.43%33.2%-24.51%32.4%-166.29%13.32%13.15%10.93%-97.51%-145.83%
EBITDA-3.1M-3.81M-5.21M-7.79M-7.54M-9.19M-12.77M-12.16M-9.39M-6.24M-6.15M-6.22M-10.2M-5.83M-7.97M-9.16M-8.28M-8.65M12.07M-10.74M
EBITDA Margin %-3191.75%-4430.23%-4010.77%-4607.1%-10921.74%-4550%-15197.62%-10047.11%-4744.95%-6368.37%-8094.74%-5452.63%-7552.53%-5892.34%-132766.67%-5486.23%-6567.46%-4857.87%526.61%-8074.44%
EBITDA Growth %58.92%58.55%59.16%35.95%19.79%-47.27%----22.77%32.15%-23.21%32.54%-166%14.68%13.02%11.13%-97.5%-145.59%
D&A (Non-Cash Add-back)6K6K5K6K6K6K4K01M0018K122.08K41.58K18K171K12K44K26K28K
EBIT-2.9M-3.58M-4.96M-7.43M-5.75M-8.6M-12.01M-12.16M-9.39M-6.24M-6.15M-6.23M-10.04M-5.88M-7.98M-9.33M-8.29M-8.69M-12.02M-10.8M
Net Interest Income0000000000000000000-3.47M
Interest Income00000000000000000000
Interest Expense00000000000000000003.47M
Other Income/Expense203K231K263K366K1.79M594K760K934K1M1.14M680K163K280K263K236K78K52K-3K-24.06M-3.51M
Pretax Income-2.9M-3.58M-4.96M-7.43M-5.75M-8.6M-12.01M-12.16M-9.39M-6.24M-6.15M-6.07M-10.04M-5.61M-7.75M-9.26M-8.23M-8.69M-12.02M-14.28M
Pretax Margin %-2988.66%-4168.6%-3812.31%-4394.08%-8328.99%-4258.91%-14297.62%-10047.11%-4744.95%-6368.37%-8094.74%-5325.44%-7435.56%-5668.69%-129133.33%-5541.92%-6535.71%-4884.27%-524.35%-10733.83%
Income Tax004K0004K000000013K000-448K0
Effective Tax Rate %0%0%-0.08%0%0%0%-0.03%0%0%0%0%0%0%0%-0.17%0%0%0%3.73%0%
Net Income-3.01M-3.58M-4.84M-7.28M-5.75M-8.61M-12.02M-12.16M-9.41M-6.25M-6.19M-6.58M-10.06M-5.62M-9.95M-9.46M-8.48M4.67M-11.57M-21.29M
Net Margin %-3100%-4168.6%-3720.77%-4307.69%-8340.58%-4262.87%-14311.9%-10047.11%-4750.51%-6376.53%-8142.11%-5775.44%-7450.37%-5678.79%-165750%-5664.07%-6726.98%2623.6%-504.8%-16003.76%
Net Income Growth %47.75%58.37%59.77%40.12%38.82%-37.8%----37.78%30.39%-18.66%-220.39%14.04%55.56%57.46%122.73%50.09%13.87%
Net Income (Continuing)-2.9M-3.58M-4.96M-7.43M-5.75M-8.6M-12.01M-12.16M-9.39M-6.24M-6.15M-6.07M-10.04M-5.61M-7.76M-9.26M-8.23M-8.69M-11.57M-14.28M
Discontinued Operations-108K0123K146K-8K-8K-8K0-11K-8K-36K-513K-20K-10K-1000K-204K-241K1000K0-1000K
Minority Interest00000000000000000000
EPS (Diluted)-3.50-4.19-7.26-8.50-6.73-10.09-14.11-14.27-11.03-7.33-10.00-2.01-3.08-1.72-2.60-2.94-2.631.52-3.89-7.36
EPS Growth %47.99%58.47%48.55%40.43%38.98%-37.65%-----284.62%31.63%-17.11%-213.16%33.16%60.05%62.32%120.08%54.45%30.63%
EPS (Basic)-3.50-4.19-7.26-8.50-6.73-10.09-14.11-14.27-11.03-7.33-10.00-2.01-3.08-1.72-2.60-2.94-2.631.52-3.89-7.36
Diluted Shares Outstanding858K855.36K666.46K856.02K855.18K853.46K851.94K851.74K851.72K851.62K621K3.28M3.27M3.26M2.98M3.22M3.22M3.08M2.97M2.89M
Basic Shares Outstanding858K855.36K666.46K856.02K855.18K853.46K851.94K851.74K851.72K851.62K621K3.28M3.27M3.26M2.98M3.22M3.22M3.08M2.97M2.89M
Dividend Payout Ratio--------------------